These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 696462

  • 1. Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.
    Price KS, Farley IJ, Hornykiewicz O.
    Adv Biochem Psychopharmacol; 1978; 19():293-300. PubMed ID: 696462
    [No Abstract] [Full Text] [Related]

  • 2. Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain.
    Walsh FX, Stevens TJ, Langlais PJ, Bird ED.
    Ann Neurol; 1982 Jul; 12(1):52-5. PubMed ID: 7114818
    [Abstract] [Full Text] [Related]

  • 3. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
    Orzi F, Fornai F, Blandini F.
    Funct Neurol; 2000 Jul; 15(4):269-76. PubMed ID: 11213530
    [No Abstract] [Full Text] [Related]

  • 4. Parkinson's disease: from brain homogenate to treatment.
    Hornykiewicz O.
    Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
    [No Abstract] [Full Text] [Related]

  • 5. The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal.
    Salminen O, Seppä T, Gäddnäs H, Ahtee L.
    J Neurosci; 1999 Sep 15; 19(18):8145-51. PubMed ID: 10479714
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1994 Jul 15; 270(1):192-7. PubMed ID: 7913495
    [Abstract] [Full Text] [Related]

  • 7. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P, Lévesque M, Parent A.
    Brain; 2007 Jan 15; 130(Pt 1):222-32. PubMed ID: 17142832
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Neuraminergic conception of extrapyramidal syndromology].
    Levin SL.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977 Jan 15; 77(2):293-9. PubMed ID: 139066
    [No Abstract] [Full Text] [Related]

  • 11. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.
    Kish SJ, Shannak K, Hornykiewicz O.
    N Engl J Med; 1988 Apr 07; 318(14):876-80. PubMed ID: 3352672
    [Abstract] [Full Text] [Related]

  • 12. Automimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia.
    Abramsky O, Litvin Y.
    Perspect Biol Med; 1978 Apr 07; 22(1):104-14. PubMed ID: 733451
    [Abstract] [Full Text] [Related]

  • 13. Role of neostriatal and mesostriatal or mesolimbic dopaminergic fibres in Parkinson's disease with and without dementia: prospects, concepts and facts.
    Cools AR.
    Yakubutsu Seishin Kodo; 1990 Mar 07; 10(1):15-34. PubMed ID: 2220127
    [No Abstract] [Full Text] [Related]

  • 14. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum.
    Kaufman MJ, Madras BK.
    Synapse; 1991 Sep 07; 9(1):43-9. PubMed ID: 1796351
    [Abstract] [Full Text] [Related]

  • 15. Brain enkephalin receptors in Parkinson's disease.
    Rinne UK, Rinne JK, Rinne JO, Laakso K, Tenovuo O, Lönnberg P, Koskinen V.
    J Neural Transm Suppl; 1983 Sep 07; 19():163-71. PubMed ID: 6321647
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A study of brain dopamine sulfate levels in relation to free dopamine and homovanillic acid in Parkinson's disease.
    Sofic E, Riederer P, Wesemann W, Kienzl E, Eichinger K, Gsell W, Jellinger K.
    J Neural Transm Park Dis Dement Sect; 1991 Sep 07; 3(4):265-71. PubMed ID: 1772579
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Striatal dopamine availability in Parkinson's disease--with reference to the wearing-off phenomenon].
    Indo T.
    Rinsho Shinkeigaku; 1984 Oct 07; 24(10):1008-16. PubMed ID: 6518691
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.